Colorectal Cancer Dataset in Xijing Hospital From 2011

Xijing Hospital40,000 enrolled

Overview

To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.

Study Type

OBSERVATIONAL

Enrollment

40,000

Conditions

Prognostic Cancer Model Chemotherapy Nutrition Related Cancer

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 1\. Pathologically confirmed colorectal adenocarcinoma, including hereditary colorectal cancer syndrome, such as Lynch syndrome and familial adenocarcinoma tumor polyposis, Peutz Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome; * 2\. Visit our center with complete medical records and pathological information; * 3\. Colorectal cancer patients diagnosed between 2013 and 2023. Exclusion Criteria: * 1\. The patient has other colorectal malignancies other than adenocarcinoma; * 2\. Malignant tumors adjacent to organs invading the colon and rectum; * 3\. Malignant tumors from distant organs metastasize to the colon and rectum; * 4\. Benign colorectal lesions; 5. Patients with recurrent colorectal cancer.

Locations (1)

Fourth Military Medical University

Xi'an, Shaanxi, China

RECRUITING

Outcomes

Primary Outcomes

overall survival

to dead or lost to follow

Time frame: from date of diagnosis until the date of death from any cause, assessed up to 120 months

DFS

disease-free survival

Time frame: from date of diagnosis until the first documented progression or recurrence, assessed up to 120 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.